Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

(2023) Maxim Grymonprez et al.   Frontiers in Pharmacology

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

(2023) Maxim Grymonprez et al.   THROMBOSIS AND HAEMOSTASIS

Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants

(2022) Kuo-Hsuan Chang et al.   Frontiers in Aging Neuroscience

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data

(2022) Lisette Warkentin et al.   Thrombosis Journal

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study

(2022) Maxim Grymonprez et al.   Frontiers in Cardiovascular Medicine

Drug–drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care

(2022) Andreas Capiau et al.   International Journal of Clinical Pharmacy

Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants

(2021) Anders Holt et al.   HEART

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population‐based nested case–control study

(2020) Yumao Zhang et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cohort selection in register‐based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade‐off between selection bias and misclassification

(2020) Maja Hellfritzsch et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

(2020) Victoria Allan et al.   Journal of Comparative Effectiveness Research

Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study

(2020) Lena M. Paschke et al.   BMC Medicine

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients

(2020) Johan Holm et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study

(2019) Nienke van Rein et al.   CIRCULATION

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding

(2019) Joris J. Komen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

(2019) Satoshi Yasuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patients with Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

(2019) Frederik Dalgaard et al.   CIRCULATION

Comparative risks of bleeding, ischemic stroke and mortality with direct oral anticoagulants versus phenprocoumon in patients with atrial fibrillation

(2018) Mariam Ujeyl et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation

(2018) Anthony P. Kent et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

(2018) Yi‐Hsin Chan et al.   Journal of the American Heart Association

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

(2018) Gene R. Quinn et al.   Journal of the American Heart Association

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

(2016) Rohan Shah et al.   AMERICAN HEART JOURNAL

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

(2016) Haiyan Xu et al.   Journal of the American Heart Association

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients With Atrial Fibrillation Taking Warfarin

(2014) Gene R. Quinn et al.   AMERICAN JOURNAL OF CARDIOLOGY

Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy

(2014) Morten Lamberts et al.   ANNALS OF INTERNAL MEDICINE

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

(2014) Morten Lamberts et al.   CIRCULATION

Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis

(2014) Doosup Shin et al.   JOURNAL OF NEUROLOGY

Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis

(2014) Sigrid Narum et al.   BMJ Open

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2013) J. H. Alexander et al.   EUROPEAN HEART JOURNAL

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis

(2012) D. G. Hackam et al.   NEUROLOGY

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins

(2008) Tom Schalekamp   ARCHIVES OF INTERNAL MEDICINE